Antibody treatment which activates the patient's own immune system against cancer, known as immunotherapy, is increasingly ...

Pitt research uncovers new insights into ovarian cancer origins, shedding light on potential early detection and treatment ...

Ovarian cancer is the deadliest form of gynecologic cancer, taking the lives of more than 13,000 women in the U.S. each year.

There are three main types of ovarian cancer: epithelial, germ cell, and stromal. Learn about each type’s defining ...

An extensive tumor genomic analysis of individuals with ovarian cancer, led by researchers from Huntsman Cancer Institute at ...

Researcher suggests compounds secreted by high-risk MSCs that are detectable in the bloodstream could act as biomarkers for ...

Researchers at the University of Pittsburgh have identified a novel trigger of a deadly form of ovarian cancer: a subset of ...

Azenosertib median duration of response (mDOR) updated to 6.3 months in the ongoing DENALI Part 1b clinical trial in patients with platinum-resistant ovarian cancer (PROC) and continues to demonstrate ...

A new type of antibody which stimulates the immune system to target cancer cells slows tumour growth, according to new ...

Tumor marker blood tests serve as a powerful diagnostic tool for many types of cancer. Learn more about how healthcare ...

AbbVie (NYSE: ABBV) today announced the final analysis of the confirmatory Phase 3 MIRASOL trial evaluating the efficacy and safety of ELAHERE® (mirvetuximab soravtansine-gynx) in women with folate ...

Optimal therapeutic targeting of cancer involves clonal signals which are expressed within all cancer cellsGradalis applies a novel clinically ...